 |
|
 |
Research, Select, & Monitor |
Wednesday, February 20, 2019 7:19:14 PM ET |
|
 |
|
|
Proteostasis Therapeutics, Inc. has an overall rank of 906 out of 6071 stocks based on 3 positive rankings and 2 negative rankings.
|
Positive Rankings |
90 Day Gain
Proteostasis Therapeutics rank is 70 |
10 Day Gain
Proteostasis Therapeutics rank is 93 |
Low Put/Call
Proteostasis Therapeutics has a low Put/Call ratio of 0.15 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Proteostasis Therapeutics is ranked 425. |
Negative Rankings |
High vPut/Call
Proteostasis Therapeutics has a high Put/Call ratio of 0.64 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Proteostasis Therapeutics is ranked 1866. |
Overbought Stochastics
Proteostasis Therapeutics rank is 2335 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
Past performance is not indicative of future results
StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.
|